Walk into any gym and you’ll find the usual suspects: caffeine, nitric oxide boosters, creatine, electrolyte mixes, and enough brightly coloured powders to stock a chemistry lab.
But there’s another contender quietly entering the conversation, and it couldn’t be more different.
Psilocybin mushrooms aren’t the first thing most people associate with exercise. Yet among atletas, biohackers and psychedelic researchers alike, there’s growing curiosity around whether very small doses might help people train with deeper focus, stronger mind-muscle connection and a greater sense of immersion.
It might sound unconventional, but the science behind the idea is becoming increasingly interesting.
Training in a State of Flow
One of the strongest arguments for psilocybin as a training aid has little to do with physical performance and everything to do with attention.
Anyone who’s experienced a great workout knows the feeling. Time fades into the background, distractions disappear and movement feels effortless. Psychologists call this estado de flujo — a condition of complete absorption where action and awareness seem to merge.
Psilocybin appears particularly good at nudging the brain toward this kind of immersive experience.
People frequently describe heightened awareness of texture, movement and subtle sensory detail after taking psilocybin, even at very low doses. Rather than constantly bouncing between thoughts, attention often becomes anchored in the present moment.
For resistance training, that could translate into a stronger mind-muscle connection. During running or cycling, it may simply make repetitive movement feel more engaging and enjoyable.
Research from the University of Amsterdam lends some support to this idea. In a preregistered study, researchers found that microdosing psilocybin increased feelings of awe and aesthetic immersion. The findings also aligned with reduced activity in the brain’s Default Mode Network — the network associated with self-referential thinking, mind wandering and internal chatter.
With that internal monologue turned down, many people report becoming more absorbed in whatever they’re doing.
What Does the Research Actually Say?
Like much of the science surrounding microdosing, the picture isn’t entirely straightforward, but that doesn’t necessarily mean nothing is happening.
The neurological effects of psilocybin are well established. Brain imaging consistently shows altered patterns of communication and changes in how sensory information is processed. What remains unclear is exactly how much of the day-to-day “microdosing experience” comes from pharmacology, and how much comes from expectation.
The most balanced conclusion is that both are probably involved.
For anyone interested in training, that still leaves an intriguing possibility: if psilocybin genuinely enhances sensory immersion while expectation boosts confidence and motivation, both factors could contribute to a better workout experience.
Beyond the Brain: Psilocybin’s Metabolic Effects
One of the most surprising developments in psychedelic research has been the growing evidence that psilocybin may influence far more than consciousness.
For years, researchers focused almost entirely on what happens inside the brain. More recent work suggests the compound may also affect metabolism, inflammation and cellular ageing throughout the body.
A 2025 estudiar from researchers at Emory University and Baylor College of Medicine, published in npj Aging, found that psilocin (the active metabolite produced after taking psilocybin) extended the lifespan of cultured human skin and lung cells by between 29% and 57%.
Importantly, there were no neurons or brain tissue involved. The researchers also administered monthly doses of psilocybin to aged mice. Compared with untreated animals, the mice lived around 30% longer while also showing healthier coats and reduced markers associated with biological ageing.
The findings suggest psilocybin may act directly on cells themselves, rather than only through the brain.
A Possible Role in Metabolic Health
Another study, published in Pharmacological Research in 2026 by a European research consortium led by Colognesi and Gabbia, explored what happened when mice eating a high-fat, high-sugar diet received tiny, non-psychedelic doses of psilocybin over twelve weeks.
The results were striking. The animals gained less weight, showed better insulin sensitivity, maintained healthier blood sugar levels and even displayed measurable improvements in fatty liver disease.
Perhaps most interestingly, these effects didn’t appear to rely on psilocybin’s famous 5-HT2A serotonin receptor — the one responsible for psychedelic experiences.
Instead, researchers traced the mechanism to 5-HT2B receptors located in the liver, suggesting psilocybin may have metabolic actions that are largely separate from its effects on consciousness.
While these findings are currently limited to animal studies, they hint that psilocybin’s biology may be much broader than originally thought.
One Biohacker’s Surprising Results
Another piece of the puzzle comes from entrepreneur Bryan Johnson, whose extensive self-tracking experiments have generated significant discussion.
Following a 5-gram psilocybin experience (not a microdose) Johnson reported notable improvements across several health markers.
His continuous glucose monitor showed improved blood sugar regulation, with mean glucose falling by around 8% and estimated HbA1c also decreasing. His inflammatory marker hsCRP dropped by more than 35%, falling below the laboratory’s detection limit.
Five days after the experience, cortisol and DHEA-S levels had fallen by 42% and 45% respectively, consistent with the relaxed “afterglow” state reported in many clinical studies after high-dose psilocybin sessions.
Johnson also recorded a substantial increase in estradiol without any reduction in testosterone, likely reflecting temporary activation of aromatase through serotonin signalling.
Of course, this remains a single self-experiment rather than clinical evidence. But viewed alongside laboratory studies exploring inflammation, metabolism and ageing, it contributes to a broader picture suggesting psilocybin’s effects extend well beyond the brain.
So… Is It Really a Pre-Workout?
Calling psilocybin a pre-workout is probably the most entertaining way to describe what’s emerging from the research, but it may also undersell what’s actually interesting.
Unlike conventional pre-workout supplements, which mostly aim to increase stimulation or blood flow, psilocybin appears to influence attention, neuroplasticity, inflammation, metabolism and potentially even cellular ageing. Those are much bigger systems than simply squeezing out another repetition on the bench press.
That doesn’t mean everyone should start microdosing before heading to the gym. Research into exercise performance specifically is still extremely limited, and much of the evidence around metabolism comes from animal studies or individual case reports rather than large human trials.
What is becoming increasingly clear, however, is that psilocybin is far more than a compound that temporarily alters consciousness. Researchers are uncovering effects throughout the body — from immune cells and liver tissue to metabolism and cellular resilience — that were almost completely overlooked just a few years ago.
If future research confirms these early findings, magic mushrooms may eventually be viewed not simply as psychedelic medicines, but as compounds with remarkably broad biological effects. The gym might just turn out to be one of the more unexpected places where people begin to notice them.
